Arnab Basu, CEO, Kromek

Arnab Basu, CEO, Kromek

Kromek has launched eVance, a new generation of CZT-based SPECT (Single Photon Emission Computed Tomography) cameras that forms a vital part of nuclear medical imaging systems used by clinicians today.

Kromeks ability to manufacture detector solutions at an economic cost will allow mainstream adoption over the next few years, which promises to enable a fundamental shift in the market allowing better images and more accurate detection, with lower energy doses and faster cycle times. The superior performance of our eVance cameras is compelling, and is sure to be a platform with a substantially long product lifecycle, said Arnab Basu, CEO, Kromek.


Vance combines Kromeks industry-leading eV-CZT detectors, fully integrated with advanced ASICs and microelectronics technology. This enables OEMs to integrate turn-key CZT cameras into almost all nuclear medical imaging system being sold today, for the diagnosis of disease based on the detection of radiation emitting from within the body. Based on clinical data from thousands of patients, the improved efficiency and image quality of CZT-based SPECT cameras is delivering superior sensitivity and specificity compared with standard scintillator cameras. The impact to the patient is better diagnostic performance while reducing their overall radiation exposure.


Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

Related Corporate Updates


whatsapp--v1